Damon DePaoli1,2, Émile Lemoine3,4, Katherine Ember3,4, Martin Parent1, Michel Prud'homme5, Léo Cantin5, Kevin Petrecca6, Frédéric Leblond3,4, Daniel C Côté1,2. 1. Université Laval, CERVO Brain Research Center, Québec, Canada. 2. Université Laval, Centre d'optique, Photonique et Lasers, Québec, Canada. 3. Polytechnique Montréal, Department of Engineering Physics, Montréal, Canada. 4. Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada. 5. Hôpital de l'Enfant-Jésus, Department of Neurosurgery, Québec, Canada. 6. McGill University, Montreal Neurological Institute-Hospital, Department of Neurology and Neurosurger, Canada.
Abstract
SIGNIFICANCE: Although the clinical potential for Raman spectroscopy (RS) has been anticipated for decades, it has only recently been used in neurosurgery. Still, few devices have succeeded in making their way into the operating room. With recent technological advancements, however, vibrational sensing is poised to be a revolutionary tool for neurosurgeons. AIM: We give a summary of neurosurgical workflows and key translational milestones of RS in clinical use and provide the optics and data science background required to implement such devices. APPROACH: We performed an extensive review of the literature, with a specific emphasis on research that aims to build Raman systems suited for a neurosurgical setting. RESULTS: The main translatable interest in Raman sensing rests in its capacity to yield label-free molecular information from tissue intraoperatively. Systems that have proven usable in the clinical setting are ergonomic, have a short integration time, and can acquire high-quality signal even in suboptimal conditions. Moreover, because of the complex microenvironment of brain tissue, data analysis is now recognized as a critical step in achieving high performance Raman-based sensing. CONCLUSIONS: The next generation of Raman-based devices are making their way into operating rooms and their clinical translation requires close collaboration between physicians, engineers, and data scientists.
SIGNIFICANCE: Although the clinical potential for Raman spectroscopy (RS) has been anticipated for decades, it has only recently been used in neurosurgery. Still, few devices have succeeded in making their way into the operating room. With recent technological advancements, however, vibrational sensing is poised to be a revolutionary tool for neurosurgeons. AIM: We give a summary of neurosurgical workflows and key translational milestones of RS in clinical use and provide the optics and data science background required to implement such devices. APPROACH: We performed an extensive review of the literature, with a specific emphasis on research that aims to build Raman systems suited for a neurosurgical setting. RESULTS: The main translatable interest in Raman sensing rests in its capacity to yield label-free molecular information from tissue intraoperatively. Systems that have proven usable in the clinical setting are ergonomic, have a short integration time, and can acquire high-quality signal even in suboptimal conditions. Moreover, because of the complex microenvironment of brain tissue, data analysis is now recognized as a critical step in achieving high performance Raman-based sensing. CONCLUSIONS: The next generation of Raman-based devices are making their way into operating rooms and their clinical translation requires close collaboration between physicians, engineers, and data scientists.
Authors: Jason T Motz; Martin Hunter; Luis H Galindo; Joseph A Gardecki; John R Kramer; Ramachandra R Dasari; Michael S Feld Journal: Appl Opt Date: 2004-01-20 Impact factor: 1.980
Authors: Brian G Saar; Christian W Freudiger; Jay Reichman; C Michael Stanley; Gary R Holtom; X Sunney Xie Journal: Science Date: 2010-12-03 Impact factor: 47.728
Authors: Conor L Evans; Xiaoyin Xu; Santosh Kesari; X Sunney Xie; Steven T C Wong; Geoffrey S Young Journal: Opt Express Date: 2007-09-17 Impact factor: 3.894
Authors: Andrew R Stevens; Clarissa A Stickland; Georgia Harris; Zubair Ahmed; Pola Goldberg Oppenheimer; Antonio Belli; David J Davies Journal: Cells Date: 2022-04-05 Impact factor: 6.600
Authors: Igor Romanishkin; Tatiana Savelieva; Alexandra Kosyrkova; Vladimir Okhlopkov; Svetlana Shugai; Arseniy Orlov; Alexander Kravchuk; Sergey Goryaynov; Denis Golbin; Galina Pavlova; Igor Pronin; Victor Loschenov Journal: Front Oncol Date: 2022-09-15 Impact factor: 5.738
Authors: Gilbert Georg Klamminger; Jean-Jacques Gérardy; Finn Jelke; Giulia Mirizzi; Rédouane Slimani; Karoline Klein; Andreas Husch; Frank Hertel; Michel Mittelbronn; Felix B Kleine-Borgmann Journal: Neurooncol Adv Date: 2021-06-18